2024. Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics. Jurnal Kimia Valensi. 10, 1 (May 2024), 27–44. DOI:https://doi.org/10.15408/jkv.v10i1.34258.